Since the start of the COVID-19 pandemic, the US Food and Drug Administration has sent numerous warning letters to companies for misrepresenting their CBD products as treatment options for patients. According to an analysis published in the Journal of Cannabis Research, cannabidiol products were among those most frequently cited by the FDA for violations. Authors […]